Drug Shortage Report for TEMODAL
Report ID | 153500 |
Drug Identification Number | 02241096 |
Brand name | TEMODAL |
Common or Proper name | temozolomide capsules |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 5CAP SACHET |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-02-18 |
Actual start date | 2022-02-17 |
Estimated end date | 2022-03-04 |
Actual end date | 2022-03-04 |
Shortage status | Resolved |
Updated date | 2022-03-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-03-05 | English | Compare |
v8 | 2022-03-04 | French | Compare |
v7 | 2022-03-04 | English | Compare |
v6 | 2022-02-18 | English | Compare |
v5 | 2022-02-17 | French | Compare |
v4 | 2022-02-17 | English | Compare |
v3 | 2022-01-26 | French | Compare |
v2 | 2022-01-26 | English | Compare |
v1 | 2022-01-26 | English | Compare |
Showing 1 to 9 of 9